BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen QH, Zheng JY, Wang DC. Asthma and stem cell therapy. World J Stem Cells 2025; 17(2): 103599 [PMID: 40061271 DOI: 10.4252/wjsc.v17.i2.103599]
URL: https://www.wjgnet.com/1948-9358/full/v17/i2/103599.htm
Number Citing Articles
1
Ahmad Z. Al Meslamani, Anan S. Jarab, Abdullah Elrefae. Advances in type 2-high asthma therapy: what remains missing?. Expert Review of Respiratory Medicine 2026; 20(1) doi: 10.1080/17476348.2025.2569844
2
Rita T. Boulos, Cynthia F. Najjoum, Vanessa J. Mansour, Elsa A. El Asmar, Nassim H. Abi Chahine. The Regentime stem cell procedure efficacy in asthma treatment: A case report. Medicine 2025; 104(24) doi: 10.1097/MD.0000000000042887
3
Qiong-Hua Chen, Jing-Yang Zheng, Yu-Qin Zhu, Jun-Yao Zhang, Chun-Yan Lin, Xue-E Zhuang, Jing Cheng, Xiao-Yi Huang. Exploring the critical therapeutic window: Dose-frequency optimization of human umbilical cord mesenchymal stem cells for preclinical asthma treatment. World Journal of Stem Cells 2025; 17(9): 109715 doi: 10.4252/wjsc.v17.i9.109715
4
Huan Yan, Imtiaz UL Hassan, Kai Yan, Man Yee Cheung, Jiani Deng, Dio Daniel Wuyang, Ke Jiang, Liangji Zhou, Luowei Yuan, Dongqing Cai, Xufeng Qi, Yong Lei, Ping Wei, Hui Zhao. Programmable RNA targeting with clustered regularly interspaced short palindromic repeats (CRISPR) effector Cas7-11 in zebrafish embryos and mammalian cells. Cell & Bioscience 2026; 16(1) doi: 10.1186/s13578-026-01632-w